Chronic Obstructive Pulmonary Disease (COPD) clinical trials
- Phase
- Phase 3
- Phase
- Phase 3
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 2/3
- Phase
- Phase 3
- Phase
- Phase 2
- Phase
- Phase 2
Access comprehensive clinical trial information for Chronic Obstructive Pulmonary Disease (COPD) through Pure Global AI's free database. This collection includes 465 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 28 trials are actively recruiting participants.
Research for Chronic Obstructive Pulmonary Disease (COPD) is being conducted in United States of America, United Kingdom, China and 7+ other countries. Leading sponsors include AstraZeneca and Novartis Pharmaceuticals. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 465 clinical trials studying Chronic Obstructive Pulmonary Disease (COPD), aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include AstraZeneca, Novartis Pharmaceuticals, Novartis Pharma Services AG, among others.